Leadership Overview
Cipla has 10 executives leading key functions including strategy, finance, information technology, sales, and marketing.
Driven by a commitment to global health, Cipla develops, manufactures, and distributes a broad range of pharmaceutical products and healthcare solutions, addressing critical therapeutic areas and enhancing patient well-being worldwide.
Driven by a commitment to global health, Cipla develops, manufactures, and distributes a broad range of pharmaceutical products and healthcare solutions, addressing critical therapeutic areas and enhancing patient well-being worldwide.
Leadership Roles at Cipla
Pravin Arya - Chief Executive Officer
Pravin Arya, the Chief Executive Officer at Cipla, directs the company's overarching strategic vision and operational execution. Arya guides the development and implementation of global business strategies, ensuring alignment with Cipla's mission to provide accessible and affordable medicines. This leadership role involves overseeing all major business segments, including Pharmaceuticals and New Ventures, and driving growth across India, the United States, South Africa, and other international markets. Pravin Arya ensures that Cipla's operations meet the highest standards of quality and compliance, fostering innovation to address unmet medical needs in areas such as cardiovascular disease, oncology, and respiratory care. The Chief Executive Officer's focus remains on expanding market reach and enhancing the company's global healthcare impact.
Upali Seneviratne - MD and Chief Executive Officer
Upali Seneviratne, the MD and Chief Executive Officer at Cipla, spearheads the company's strategic direction and global expansion initiatives. Seneviratne oversees the comprehensive business operations, driving innovation and operational excellence across Cipla's diverse portfolio. This executive leadership position involves managing relationships with key stakeholders and ensuring the successful execution of long-term growth strategies in critical markets. Upali Seneviratne's mandate includes enhancing Cipla's presence in therapeutic areas like HIV/AIDS, diabetes, and infectious diseases, while also exploring new ventures in biosimilars and specialty medicines. The MD and Chief Executive Officer's efforts are focused on strengthening Cipla's position as a leading global pharmaceutical entity.
Achin Gupta - Global Chief Executive Officer & Managing Director
Achin Gupta, the Global Chief Executive Officer & Managing Director at Cipla, orchestrates the company's worldwide strategic operations and market development. Gupta drives the execution of Cipla's global business plan, focusing on expanding its footprint in key international regions and strengthening its product pipeline. This leadership position encompasses overseeing all aspects of the pharmaceutical business, from research and development to manufacturing and distribution, ensuring accessibility of medicines across diverse therapeutic areas. Achin Gupta's strategic initiatives aim to enhance Cipla's competitive edge in generic and branded generic markets, particularly in oncology, respiratory care, and critical care segments. The Global Chief Executive Officer & Managing Director's vision is to solidify Cipla's role as a significant contributor to global health outcomes.

Ashish Vig - Chief Executive Officer, Cipla Digital Health & Leader (Ecommerce, Modern Trade, Organized Retail Pharmacies)
Ashish Vig, the Chief Executive Officer, Cipla Digital Health & Leader (Ecommerce, Modern Trade, Organized Retail Pharmacies) at Cipla, spearheads the company's digital health initiatives and omnichannel retail strategies. Vig drives the expansion of Cipla's e-commerce presence and optimizes engagement with modern trade and organized retail pharmacy channels across India and other key markets. This leadership role focuses on leveraging digital platforms to enhance patient access to medicines and healthcare solutions, particularly in areas like chronic disease management and wellness. Ashish Vig's strategic direction aims to build a robust digital ecosystem that complements Cipla's traditional pharmaceutical business. The Chief Executive Officer, Cipla Digital Health's efforts are crucial for adapting to evolving consumer behaviors and market dynamics.
C.A. Kadam - Chief Financial Officer
C.A. Kadam, the Chief Financial Officer at Cipla, directs all financial operations and fiscal strategy for the global organization. Kadam manages financial planning, budgeting, and reporting, ensuring robust financial health and compliance across all business segments. This critical role involves overseeing capital allocation, investment strategies, and risk management to support Cipla's growth objectives in India and international markets. C.A. Kadam's responsibilities extend to optimizing financial performance and driving shareholder value through prudent financial stewardship. The Chief Financial Officer's expertise is vital in navigating complex financial landscapes and supporting the company's expansion into new ventures and therapeutic areas.
Lucia Van Konynenburg - PA To the Chief Operating Officer
Lucia Van Konynenburg, the PA To the Chief Operating Officer at Cipla, provides essential administrative and operational support to the Chief Operating Officer, facilitating the smooth execution of daily activities and strategic initiatives. Van Konynenburg manages complex scheduling, coordinates meetings, and handles critical communications, ensuring efficient workflow within the COO's office. This role is integral to maintaining operational continuity and supporting the strategic objectives of Cipla's global operations. Lucia Van Konynenburg's meticulous attention to detail and organizational skills are vital for managing the demands of a high-level executive position. The PA To the Chief Operating Officer's contribution ensures that key operational decisions are made effectively and efficiently.
Sneha Hiranandani - Chief Information Officer
Sneha Hiranandani, the Chief Information Officer at Cipla, leads the company's technology strategy and digital transformation initiatives. Hiranandani oversees the development and implementation of robust IT infrastructure, ensuring data security, operational efficiency, and seamless integration of digital solutions across Cipla's global operations. This role is pivotal in leveraging technology to enhance research and development, streamline manufacturing processes, and improve customer engagement. Sneha Hiranandani's focus includes driving innovation in areas like data analytics and cloud computing to support Cipla's expansion in pharmaceuticals, biosimilars, and consumer healthcare. The Chief Information Officer's leadership ensures Cipla remains at the forefront of technological advancements in the healthcare industry.
Kanchan Israni - Chief Revenue Officer, Category Lead Outsourcing
Kanchan Israni, the Chief Revenue Officer, Category Lead Outsourcing at Cipla, directs revenue generation strategies and oversees the outsourcing business segment. Israni is responsible for driving sales growth and maximizing revenue streams across Cipla's diverse product categories, with a specific focus on the outsourcing of pharmaceutical manufacturing and services. This executive position involves developing and executing commercial strategies to expand market share and forge strategic partnerships globally. Kanchan Israni's leadership ensures that Cipla's outsourcing division operates efficiently and profitably, contributing significantly to the company's overall financial performance. The Chief Revenue Officer's efforts are critical in maintaining Cipla's competitive position in the global pharmaceutical market.
Sagar Laddha - Chief Sales Officer (CSO)
Sagar Laddha, the Chief Sales Officer (CSO) at Cipla, leads the company's global sales force and drives revenue growth across all markets. Laddha develops and implements comprehensive sales strategies, focusing on expanding market penetration and strengthening customer relationships. This executive role involves overseeing sales operations, managing key accounts, and ensuring the effective promotion and distribution of Cipla's pharmaceutical products. Sagar Laddha's leadership is instrumental in achieving sales targets and enhancing Cipla's market presence in therapeutic areas such as cardiovascular disease, respiratory conditions, and oncology. The Chief Sales Officer's strategic vision is crucial for driving commercial success and reinforcing Cipla's commitment to patient access.
Rohidas Patil - Sr. Executive Chief Marketing Officer Operations
Rohidas Patil, the Sr. Executive Chief Marketing Officer Operations at Cipla, directs the operational aspects of Cipla's marketing strategies and execution across its diverse product portfolio. Patil oversees the implementation of marketing campaigns, ensuring alignment with business objectives and market demands in India and international territories. This role focuses on optimizing marketing resource allocation, enhancing brand visibility, and driving market share for Cipla's pharmaceutical offerings, including generics, branded generics, and specialty medicines. Rohidas Patil's operational expertise is critical for translating marketing strategies into tangible market impact, particularly in therapeutic areas like HIV/AIDS, diabetes, and respiratory care. The Sr. Executive Chief Marketing Officer Operations' contributions are vital for sustained commercial growth.
Explore Leadership Teams in Manufacturing
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership NR
BS
EG
Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA is a multinational pharmaceutical, chemical and life sciences company. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing.
Company Leadership GL
JR
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The companys lead product is Translarna (ataluren), for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.
Company Leadership
JB
LG
Headquartered in Incheon, Korea, Celltrion is a leading biopharmaceutical company, specializing in research, development and manufacturing of biosimilar and innovative drugs. Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EC's approval for Inflectra® and Remsima®, respectively, which is the world's first mAb biosimilar to receive approval from a regulatory agency in a developed country.
Company Leadership DK
JS
YH
LS